[1] 胡亚美, 江载芳. 诸福棠实用儿科学(第七版). 北京: 人民卫生出版社, 2002: 1956-1958.
[2] Sindi IA, Tannenberg RK, Dodd PR. Role for the neurexin-neuroligin complex in Alzheimer's disease. Neurobiol Aqinq , 2014, 35(4): 746-756.
[3] Bourne Y, Marchot P. The neuroligins and their ligands: from structure to function at the synapse. J Mol Neurosci , 2014, 53(3): 387-396.
[4] Xiang YY, Dong HH, Yang BB, MacDonald JF, Lu WY. Interaction of acetylcholinesterase with neurexin-1β regulates glutamatergic synaptic stability in hippocampal neurons. Mol Brain , 2014, 7: 15.
[5] Born G, Breuer D, Wang SP, Rohlmann A, Coulon P, Vakili P, Reissner C, Kiefer F, Heine M, Pape HC, Missler M. Modulation of synaptic function through the α-neurexin- specific ligand neurexophilin-1. Proc Natl Acad Sci USA , 2014, 111(13): 1274-1283.
[6] Bang ML, Owczarek S. A matter of balance: role of neurexin and neuroligin at the synapse. Neurochem Res , 2013, 38(6): 1174-1189.
[7] Rowen L, Young J, Birditt B, Kaur A, Madan A, Philipps DL, Qin SZ, Minx P, Wilson RK, Hood L, Graveley BR. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics , 2002, 79(4): 587-597.
[8] Graf ER, Kang Y, Hauner AM, Craig AM. Structure function and splice site analysis of the synaptogenic activity of the neurexin-1β LNS domain. J Neurosci , 2006, 26(16): 4256-4265.
[9] Treutlein B, Gokce O, Quake SR, Südhof TC. Cartography of neurexin alternative splicing mapped by single-molecule long-read mRNA sequencing. Proc Natl Acad Sci USA , 2014, 111(13): E1291-E1299.
[10] Shen KC, Kuczynska DA, Wu IJ, Murray BH, Sheckler LR, Rudenko G. Regulation of neurexin 1beta tertiary structure and ligand binding through alternative splicing. Structure , 2008, 16(3): 422-431.
[11] Missler M, Südhof TC, Biederer T. Synaptic cell adhesion. Cold Spring Harb Perspectives Biol , 2012, 4(4): a005694.
[12] Futai K, Doty CD, Baek B, Ryu J, Sheng M. Specific Trans -synaptic interaction with inhibitory interneuronal neurexin underlies differential ability of neuroligins to induce functional inhibitory synapses. J Neurosci , 2013, 33(8): 3612-3623.
[13] Reissner C, Runkel F, Missler M. Neurexins. Genome Biol , 2013, 14(9): 213.
[14] Missler M, Südhof TC. Neurexins: Three genes and 1001 products. Trends Genet , 1998, 14(1): 20-26.
[15] Davletov BA, Krasnoperov V, Hata Y, Petrenko AG, Südhof TC. High affinity binding of α-latrotoxin to recombinant neurexin Iα. J Biol Chem , 1995, 270(41): 23903-23905.
[16] Missler M, Fernandez-Chacon R, Südhof TC. The making of neuexins. J Neurochem , 1998, 71(4): 1339-1347.
[17] Runkel F, Rohlmann A, Reissner C, Brand SM, Missler M. Promoter-like sequences regulating transcriptional activity in neurexin and neuroligin gene. J Neurochem , 2013, 127(1): 36-47.
[18] Miyake T, Loch CM, Li R. Identification of a multifunctional domain in autonomously replicating sequence-binding factor 1 required for transcriptional activation, DNA replication, and gene silencing. Mol Cell Biol , 2002, 22(2): 505-516.
[19] Klugmann M, Leichtlein CB, Symes CW, Klaussner BC, Brooks AI, Young D, During MJ. A novel role of circadian transcription factor DBP in hippocampal plasticity. Mol Cell Neurosci , 2006, 31(2): 303-314.
[20] Liu YL, Hu ZM, Xun GL, Peng Y, Lu LN, Xu XJ, Xiong ZM, Xia L, Liu DY, Li W, Zhao JP, Xia K. Mutation analysis of the NRXN1 gene in a Chinese autism cohort. J Psychiatr Res , 2012, 46(5): 630-634.
[21] Feng JN, Schroer R, Yan J, Song WJ, Yang CM, Bockholt A, Cook EH Jr, Skinner C, Schwartz CE, Sommer SS. High frequency of neurexin 1β signal peptide structural variants in patients with autism. Neurosci Lett , 2006, 409(1): 10-13.
[22] Autism Genome Project Consortium, Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent J
